BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38649280)

  • 21. Co-deficiency of B7-H3 and B7-H4 identifies high CD8 + T cell infiltration and better prognosis in pancreatic cancer.
    Si S; Wang L; Cao H; Xu Y; Zhan Q
    BMC Cancer; 2022 Feb; 22(1):211. PubMed ID: 35219310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell exhaustion interrelates with immune cytolytic activity to shape the inflamed tumor microenvironment.
    Cai MC; Zhao X; Cao M; Ma P; Chen M; Wu J; Jia C; He C; Fu Y; Tan L; Xue X; Yu Z; Zhuang G
    J Pathol; 2020 Jun; 251(2):147-159. PubMed ID: 32222046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiomic models based on magnetic resonance imaging predict the spatial distribution of CD8
    Jeon SH; Kim SW; Na K; Seo M; Sohn YM; Lim YJ
    Front Immunol; 2022; 13():1080048. PubMed ID: 36601118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumoral CXCL13
    Dai S; Zeng H; Liu Z; Jin K; Jiang W; Wang Z; Lin Z; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Qu Y; Guo J; Xu J
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. m
    Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
    Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer.
    Liu SY; Dong ZY; Wu SP; Xie Z; Yan LX; Li YF; Yan HH; Su J; Yang JJ; Zhou Q; Zhong WZ; Tu HY; Yang XN; Zhang XC; Wu YL
    Lung Cancer; 2018 Nov; 125():86-92. PubMed ID: 30429043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOD3 induces a HIF-2α-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells.
    Carmona-Rodríguez L; Martínez-Rey D; Fernández-Aceñero MJ; González-Martín A; Paz-Cabezas M; Rodríguez-Rodríguez N; Pérez-Villamil B; Sáez ME; Díaz-Rubio E; Mira E; Mañes S
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32591431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
    Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
    World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ITGAL expression in non-small-cell lung cancer tissue and its association with immune infiltrates.
    Zhang R; Zhu G; Li Z; Meng Z; Huang H; Ding C; Wang Y; Chen C; Li Y; Liu H; Chen J
    Front Immunol; 2024; 15():1382231. PubMed ID: 38646528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression patterns associated with tumor-infiltrating CD4+ and CD8+ T cells in invasive breast carcinomas.
    Wang Z; Yang X; Shen J; Xu J; Pan M; Liu J; Han S
    Hum Immunol; 2021 Apr; 82(4):279-287. PubMed ID: 33612391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infiltration by Intratumor and Stromal CD8 and CD68 in Cervical Cancer.
    Dimitrova P; Vasileva-Slaveva M; Shivarov V; Hasan I; Yordanov A
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109686
    [No Abstract]   [Full Text] [Related]  

  • 32. The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients.
    López-Janeiro Á; Villalba-Esparza M; Brizzi ME; Jiménez-Sánchez D; Ruz-Caracuel I; Kadioglu E; Masetto I; Goubert V; Garcia-Ros D; Melero I; Peláez-García A; Hardisson D; de Andrea CE
    J Pathol; 2022 Dec; 258(4):426-436. PubMed ID: 36169332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.
    Zhao B; Wang Y; Wang Y; Dai C; Wang Y; Ma W
    Front Immunol; 2021; 12():557994. PubMed ID: 34220791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD8
    Zheng X; Jiang K; Xiao W; Zeng D; Peng W; Bai J; Chen X; Li P; Zhang L; Zheng X; Miao Q; Wang H; Wu S; Xu Y; Xu H; Li C; Li L; Gao X; Zheng S; Li J; Wang D; Zhou Z; Xia X; Yang S; Li Y; Cui Z; Zhang Q; Chen L; Lin X; Lin G
    Front Immunol; 2022; 13():974265. PubMed ID: 36439099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer.
    Sugie T; Sato E; Miyashita M; Yamaguchi R; Sakatani T; Kozuka Y; Moritani S; Suzuki E; Kakimi K; Mikami Y; Moriya T
    Breast Cancer; 2020 Jul; 27(4):519-526. PubMed ID: 32447649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Immunological Characteristics and Genomic Alterations in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Based on PD-L1 Expression.
    Xu SM; Shi CJ; Xia RH; Wang LZ; Tian Z; Ye WM; Liu L; Liu SL; Zhang CY; Hu YH; Zhou R; Han Y; Wang Y; Zhang ZY; Li J
    Front Immunol; 2021; 12():798424. PubMed ID: 35145511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential gene expression of tumor-infiltrating CD8
    Saleh R; Sasidharan Nair V; Toor SM; Taha RZ; Murshed K; Al-Dhaheri M; Khawar M; Petkar MA; Abu Nada M; Al-Ejeh F; Elkord E
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32948653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A gene signature for immune subtyping of desert, excluded, and inflamed ovarian tumors.
    Mlynska A; Vaišnorė R; Rafanavičius V; Jocys S; Janeiko J; Petrauskytė M; Bijeikis S; Cimmperman P; Intaitė B; Žilionytė K; Barakauskienė A; Meškauskas R; Paberalė E; Pašukonienė V
    Am J Reprod Immunol; 2020 Jul; 84(1):e13244. PubMed ID: 32294293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
    Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
    Front Immunol; 2020; 11():550250. PubMed ID: 33193316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of a PD-L1/PD-1/CD8 axis-based classifier to predict cancer survival of upper tract urothelial carcinoma after radical nephroureterectomy.
    Chen J; Zhong W; Yang M; Hou W; Wang X; Xia K; Yu H; Yang M; Zhou B; Wang B; Huang J; Lin T
    Cancer Immunol Immunother; 2021 Sep; 70(9):2657-2668. PubMed ID: 33606065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.